A pathological role of GAD65Ab was initially rejected based on (1) the intracellular localization of GAD65 and (2) the association of GAD65Ab with various types of neurological diseases, including CAs, stiff-person syndrome (SPS), and epilepsy [2]. This evidence concerns the gene GAD2 and epilepsy.